title: Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC 2000 Registry.
authors.affiliation: Service de Cardiologie, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, 75015 Paris, France. nicolas.danchin@egp.ap-hop-paris.fr.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Danchin
authors.forename: Didier
authors.initials: D
authors.lastname: Blanchard
authors.forename: Philippe Gabriel
authors.initials: PG
authors.lastname: Steg
authors.forename: Patrick
authors.initials: P
authors.lastname: Sauval
authors.forename: Guy
authors.initials: G
authors.lastname: Hanania
authors.forename: Patrick
authors.initials: P
authors.lastname: Goldstein
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Cambou
authors.forename: Pascal
authors.initials: P
authors.lastname: Guéret
authors.forename: Laurent
authors.initials: L
authors.lastname: Vaur
authors.forename: Youcef
authors.initials: Y
authors.lastname: Boutalbi
authors.forename: Nathalie
authors.initials: N
authors.lastname: Genès
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Lablanche
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000706:statistics & numerical data; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D019090:Case Management / Q000706:statistics & numerical data; D015331:Cohort Studies; D003131:Combined Modality Therapy; D004632:Emergency Medical Services / Q000379:methods / Q000706:statistics & numerical data; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005602:France / Q000453:epidemiology; D006493:Heparin / Q000627:therapeutic use; D017052:Hospital Mortality; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D007362:Intensive Care Units / Q000706:statistics & numerical data; D015993:Life Tables; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D009204:Myocardial Revascularization / Q000706:statistics & numerical data; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011446:Prospective Studies; D012042:Registries; D012306:Risk; D016019:Survival Analysis; D015996:Survival Rate; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D005343:Fibrinolytic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D006493:Heparin